EventItem
 
 
 
     
    Patient Cost-Sharing for Prescription Drugs: Policy Issues

    2/16/2018








    A USC-Brookings Schaeffer Initiative for Health Policy Event


    Friday | February 16, 2018
    9:00 AM- 11:00 AM ET

    The Brookings Institution
    Falk Auditorium
    1775 Massachusetts Ave, NW
    Washington, DC 20036



    Prescription drug costs continue to grow in the U.S. due to both price hikes for existing drugs and the development of expensive new therapies. In Medicare, these costs now account for $1 out of every $6 in spending. As costs grow, particularly for specialty drugs and novel therapies, patients can face high cost-sharing burdens, and the Medicare benefit places no limit on a patient’s out-of-pocket spending for prescription drugs. Moreover, while increased rebates have often mitigated the growth in net drug prices, many patients still pay cost-sharing based on a percentage of the gross (pre-rebate) drug price.

    On Friday, February 16, the USC-Brookings Schaeffer Initiative for Health Policy will host a conference on the policy issues surrounding patient drug cost sharing. Two panels will convene, first to discuss restructuring the Medicare Part D benefit design, and then to debate the effectiveness of mechanisms to reduce cost sharing for commercially insured patients. 

    Join the conversation on Twitter at #RxCostSharing

     
    9:00 AM   Welcome and Overview
    Paul Ginsburg, Director, USC-Brookings Schaeffer Initiative for Health Policy

    9:05 AM   Panel 1: Revamping the Medicare Part D Benefit Design
    Should Medicare Beneficiaries' Out-of-Pocket Expenditures be Capped?

    Paul Ginsburg (Moderator), Director, USC-Brookings Schaeffer Initiative for Health Policy
    Erin Trish, Associate Director of Health Policy, USC Schaeffer Center for Health Policy & Economics
    Douglas Holtz-Eakin, President, American Action Forum
    Elizabeth Jurinka, Chief Health Advisor (D), U.S. Senate Committee on Finance
    Nicholas Uehlecke, Professional Staff Member (R), U.S. House of Representatives, Committee on Ways and Means, Subcommittee on Health 

    10:00 AM  Panel 2: Mechanisms to Reduce Cost Sharing for Commercially-Insured Patients
    Margot Sanger-Katz (Moderator), New York Times
    Geoff Joyce, Director of Health Policy, USC Schaeffer Center for Health Policy & Economics
    Fiona Scott Morton, Theodore Nierenberg Professor of Economics, Yale University School of Management 
    Adam Fein, President, Pembroke Consulting, Inc., CEO, Drug Channels Institute
    Elizabeth Fowler, Vice President, Global Health Policy, Johnson & Johnson
    Steven Miller, Chief Medical Officer, Express Scripts

    11:00 AM  Adjourn